Tumor-derived miRNAs in serum are emerging as the new noninvasive biomarkers for the diagnosis of human cancers, especially at their early stage. An ideal method with high sensitivity, excellent selectivity, a simple procedure, and small amounts of starting materials is imperative for the detection of clinic circulating miRNAs. Here, we develop a new method for isothermally sensitive detection of serum miRNAs using hairpin probe-based rolling circle amplification (HP-RCA). This method exhibits ultrahigh sensitivity toward lung cancer-related miR-486-5p with a detection limit of as low as 10 fM and a large dynamic range of 6 orders of magnitude, and it can even discriminate miR-486-5p from both miRNAs with high sequence homology and its prec...
Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Early diagnosis is ...
Lung cancer (LC) is currently the world’s leading cause of cancer-related mortality with overall mor...
Circulating microRNAs (c-miRNAs) are emerging as new non-invasive biomarkers for human cancers diagn...
BackgroundNon-small cell lung cancer (NSCLC) accounts for about 85% of lung cancers. This study aime...
MicroRNAs have been reported as related to multiple diseases and have potential applications in diag...
Lung cancer is the main cause of cancer-related mortality worldwide. Patients with early stage (I-II...
Abstract Background Lung cancer is one of the most common solid tumors worldwide and the leading cau...
Non small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality world-wide and t...
Lung cancer is the most common cause of cancer deaths worldwide and numerous ongoing research effort...
<div><p>Non small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality world-wi...
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide. Currently, the...
Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reaso...
Lung cancer is the most common cause of cancer deaths all over the world, in which non-small cell lu...
Cell-free microRNAs in plasma provide circulating biomarkers for lung cancer. Most techniques for an...
Introduction:The ability to diagnose non-small cell lung cancer (NSCLC) at an early stage may lead t...
Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Early diagnosis is ...
Lung cancer (LC) is currently the world’s leading cause of cancer-related mortality with overall mor...
Circulating microRNAs (c-miRNAs) are emerging as new non-invasive biomarkers for human cancers diagn...
BackgroundNon-small cell lung cancer (NSCLC) accounts for about 85% of lung cancers. This study aime...
MicroRNAs have been reported as related to multiple diseases and have potential applications in diag...
Lung cancer is the main cause of cancer-related mortality worldwide. Patients with early stage (I-II...
Abstract Background Lung cancer is one of the most common solid tumors worldwide and the leading cau...
Non small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality world-wide and t...
Lung cancer is the most common cause of cancer deaths worldwide and numerous ongoing research effort...
<div><p>Non small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality world-wi...
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide. Currently, the...
Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reaso...
Lung cancer is the most common cause of cancer deaths all over the world, in which non-small cell lu...
Cell-free microRNAs in plasma provide circulating biomarkers for lung cancer. Most techniques for an...
Introduction:The ability to diagnose non-small cell lung cancer (NSCLC) at an early stage may lead t...
Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Early diagnosis is ...
Lung cancer (LC) is currently the world’s leading cause of cancer-related mortality with overall mor...
Circulating microRNAs (c-miRNAs) are emerging as new non-invasive biomarkers for human cancers diagn...